Immunoassay Reagent CEDIA® Digitoxin CLIA Non-Waived For Clinical Chemistry Analyzers

Name: Immunoassay Reagent
Brand: CEDIA®

REAGENT, IMMUNOASSAY CEDIA DIGITOXIN 17X13ML

McKesson #

1254918

Manufacturer #

100004

Brand

CEDIA®

Manufacturer

Fisher Scientific

Country of Origin

Unknown

Application

Immunoassay Reagent

CLIA Classification

CLIA Non-Waived

CLIA Classified

CLIA Non-Waived

Container Type

Bottle

For Use With

For Clinical Chemistry Analyzers

Product Dating

McKesson Acceptable Dating: we will ship >= 90 days

Sample Type

Serum Sample

Specialty

Immunoassay

Storage Requirements

Requires Refrigeration

Test Category

Therapeutic Drug Monitoring

Test Method

Homogenous Enzyme Immunoassay (HEIA)

Test Name

Digitoxin

UNSPSC Code

41116007

Volume

R1: 17 mL, R2: 13 mL

The CEDIA Digitoxin Assay is an in vitro diagnostic medical device intended for the quantitative determination of digitoxin in human serum
The CEDIA Digitoxin assay uses recombinant DNA technology (US Patent No. 4708929) to produce a unique homogeneous enzyme immunoassay system
Chemistry analyzers capable of maintaining a constant temperature, pipetting samples, mixing reagents, measuring enzymtic rates and timing the reaction accurately can be used to perform this assay